Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Stomatitis 1Neoplasm Metastasis 1Nasopharyngeal Neoplasms 1Melanoma 1Malignant Ascites 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 12Radiotherapy 6Gemcitabine 6Paclitaxel 5Fluorouracil 4Radiotherapy, Intensity-Modulated 3Docetaxel 3spartalizumab 2sintilimab 2nimotuzumab 2camrelizumab 2Surveys and Questionnaires 2Endostatins 2Carboplatin 2triethanolamine 1toripalimab 1regramostim 1fluzoparib 1fluoromisonidazole 1endostar protein 1Vitamin B 12 1Tomography, Optical Coherence 1Taxes 1Rubidium-82 1Ritonavir 1Re-Irradiation 1Procaine 1Oxaliplatin 1Magnetic Resonance Spectroscopy 1Liquid Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Nasopharyngeal Neoplasms × regramostim × Clear all
NCT01806272 2013-03-29

Recombinant Human Granulocyte Macrophage Colony Stimulating Factor(rhGM-CSF) Treating Oral Mucositis

Sun Yat-sen University

Phase 2 Unknown
160 enrolled
Head & Neck

Nasopharyngeal Neoplasms, Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡